Correlation Between Karyopharm Therapeutics and Heron Therapeuti

Can any of the company-specific risk be diversified away by investing in both Karyopharm Therapeutics and Heron Therapeuti at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Karyopharm Therapeutics and Heron Therapeuti into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Karyopharm Therapeutics and Heron Therapeuti, you can compare the effects of market volatilities on Karyopharm Therapeutics and Heron Therapeuti and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Karyopharm Therapeutics with a short position of Heron Therapeuti. Check out your portfolio center. Please also check ongoing floating volatility patterns of Karyopharm Therapeutics and Heron Therapeuti.

Diversification Opportunities for Karyopharm Therapeutics and Heron Therapeuti

-0.17

Correlation Coefficient

Karyopharm Therapeutics  Heron Therapeuti

Good diversification

The 3 months correlation between Karyopharm and Heron is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Karyopharm Therapeutics and Heron Therapeuti in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Heron Therapeuti and Karyopharm Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Karyopharm Therapeutics are associated (or correlated) with Heron Therapeuti. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Heron Therapeuti has no effect on the direction of Karyopharm Therapeutics i.e., Karyopharm Therapeutics and Heron Therapeuti go up and down completely randomly.

Pair Corralation between Karyopharm Therapeutics and Heron Therapeuti

Given the investment horizon of 90 days Karyopharm Therapeutics is expected to generate 1.03 times more return on investment than Heron Therapeuti. However, Karyopharm Therapeutics is 1.03 times more volatile than Heron Therapeuti. It trades about 0.07 of its potential returns per unit of risk. Heron Therapeuti is currently generating about -0.09 per unit of risk. If you would invest  71.00  in Karyopharm Therapeutics on September 4, 2024 and sell it today you would earn a total of  12.00  from holding Karyopharm Therapeutics or generate 16.9% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.44%
Values	Daily Returns

Karyopharm Therapeutics  vs.  Heron Therapeuti

Karyopharm Therapeutics

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Karyopharm Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Karyopharm Therapeutics demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Heron Therapeuti

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Heron Therapeuti has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Karyopharm Therapeutics and Heron Therapeuti

The main advantage of trading using opposite Karyopharm Therapeutics and Heron Therapeuti positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Karyopharm Therapeutics position performs unexpectedly, Heron Therapeuti can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Heron Therapeuti will offset losses from the drop in Heron Therapeuti's long position.

The idea behind Karyopharm Therapeutics and Heron Therapeuti pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.